The kidneys become hard and small with buildup of amyloid. It is important for the nurse to assess the extent of kidney involvement in amyloidosis and the development of the nephrotic syndrome.
The litany of failed trials of amyloid-targeting drugs for ... Roche terminated two phase 3 trials of crenezumab in people with prodromal to mild sporadic Alzheimer's in early 2019 after interim ...
AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months.